A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

by | Sep 24, 2025 | Clinical Trials | 0 comments

​ Conditions: Autoimmune Hemolytic Anemia

Interventions: Drug: enatumab

Sponsors: Bing Han

Not yet recruiting Conditions: Autoimmune Hemolytic Anemia
Interventions: Drug: enatumab
Sponsors: Bing Han
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *